Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma
Rita De Sanctis(Humanitas University), Armando Santoro(IRCCS Humanitas Research Hospital), Vittorio Quagliuolo(Humanitas University), Stefano Bastoni(Istituto Ortopedico Gaetano Pini), Luca Balzarini(Humanitas University), Alexia Bertuzzi(Humanitas University), Silvia Marchetti(Institute of Cancer Research), Chiara Mussi(University of Modena and Reggio Emilia), Romano Fabio Lutman(Humanitas University), Andrea Marrari(IRCCS Humanitas Research Hospital), Primo Andrea Daolio(Istituto Ortopedico Gaetano Pini)
Cited by 41
Related Papers
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
|JAMA|2014|569
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
|The Lancet Oncology|2012|550
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532